ECSP961773A - METHODS TO MINIMIZE LOSS OSEA X-10208 - Google Patents

METHODS TO MINIMIZE LOSS OSEA X-10208

Info

Publication number
ECSP961773A
ECSP961773A ECSP961773A ECSP961773A EC SP961773 A ECSP961773 A EC SP961773A EC SP961773 A ECSP961773 A EC SP961773A EC SP961773 A ECSP961773 A EC SP961773A
Authority
EC
Ecuador
Prior art keywords
pyrrodinyl
osea
methods
minimize loss
graph
Prior art date
Application number
Other languages
Spanish (es)
Inventor
George Joseph Cullinan
Steven A Fontana
Young Robin S Fuchs
Andrew L Glasebrook
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961773 priority Critical patent/ECSP961773A/en
Publication of ECSP961773A publication Critical patent/ECSP961773A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se refiere a la utilización de un compuesto de la fórmula II:(gráfico), en que cada R1 es independientemente -H, -OH, -O(alquil C1-C4), -OCOC6H5, -OCO(alquil C1-C6), y R2 es 1-piperidinil, 1-pirrodinil, metil-1-pirrodinil, dimetil-1-pirrodinil, 4-morfolino, dimetilamino, dietilamino, o 1-hexametilenoimino; o, una sal derivada de estos que sea farmacéuticamente aceptable, en la preparación de un medicamento útil en la minimización de los efectos de pérdida ósea de un compuesto de la fórmula I (gráfico), en que R es -CH2CON(CH3) -n- CH2CH2CH2CH3 o-SO(CH2)3CF2CF3 o una sal derivada de estos que sea farmacéuticamente aceptable.The invention relates to the use of a compound of formula II: (graph), in which each R1 is independently -H, -OH, -O (C1-C4 alkyl), -OCOC6H5, -OCO (C1-C6 alkyl ), and R2 is 1-piperidinyl, 1-pyrrodinyl, methyl-1-pyrrodinyl, dimethyl-1-pyrrodinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or, a pharmaceutically acceptable salt derived from these, in the preparation of a medicament useful in minimizing the bone loss effects of a compound of formula I (graph), wherein R is -CH2CON (CH3) -n - CH2CH2CH2CH3 or-SO (CH2) 3CF2CF3 or a salt derived from these that is pharmaceutically acceptable.

ECSP961773 1996-06-05 1996-06-05 METHODS TO MINIMIZE LOSS OSEA X-10208 ECSP961773A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961773 ECSP961773A (en) 1996-06-05 1996-06-05 METHODS TO MINIMIZE LOSS OSEA X-10208

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961773 ECSP961773A (en) 1996-06-05 1996-06-05 METHODS TO MINIMIZE LOSS OSEA X-10208

Publications (1)

Publication Number Publication Date
ECSP961773A true ECSP961773A (en) 1998-04-24

Family

ID=42042503

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961773 ECSP961773A (en) 1996-06-05 1996-06-05 METHODS TO MINIMIZE LOSS OSEA X-10208

Country Status (1)

Country Link
EC (1) ECSP961773A (en)

Similar Documents

Publication Publication Date Title
PT788356E (en) METHOD AND COMPOSITIONS FOR THE INHIBITION OF PROTEIN-KINASES.
CO5721006A2 (en) DERIVATIVES OF PIRAZOLO-QUINAZOLINA, PROCESS FOR ITS PREPARATION AND ITS USE AS QUINASE INHIBITORS
ES2094721T3 (en) ANALOGS OF THE CAMPTOTECINE SOLUBLE IN WATER.
AR015649A1 (en) INHIBITORS OF PROTEIC ISOPRENYL-TRANSFERS, COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
DK568885A (en) SURE INDOLIC COMPOUNDS AND THEIR USE AS ANTIALLERGIC AGENTS
HUP0001192A2 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
BR9607017A (en) Compound and use thereof
PE20212302A1 (en) APOL1 INHIBITORS AND THEIR METHODS OF USE
DK0562956T3 (en) New Naphthylalkylamines, Methods of Preparation and Pharmaceutical Agents Containing Them
EA199900937A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING VORIKONAZOL
ES2171428T3 (en) DERIVATIVES OF GALANTAMINE, A PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
RU97117350A (en) INTIMA HYPERTROPHY INHIBITOR, OXINDOL DERIVATIVE APPLICATION FOR THE INIMA HYPERTROPHY INHIBITOR INHIBITOR, A COMPOSITION FOR INHIBITING INTIMA HYPERTROPHY, PREVENTION AND TREATMENT HYPERT
DE69728544D1 (en) TOTAL SYNTHESIS OF ACYL FULVENES WITH ANTITUARY EFFECT
ATE380797T1 (en) PRENYL TRANSFERASE INHIBITORS
TR199701507T1 (en) Methods for minimizing bone loss.
ES2179523T3 (en) METHOD TO INCREASE THE BIODISPONIBILITY OF FEXOFENADINE AND ITS DERIVATIVES.
DK0399519T3 (en) Potentiation of cell-mediated immunity using polyamine derivatives
ECSP961773A (en) METHODS TO MINIMIZE LOSS OSEA X-10208
ES2136614T3 (en) DERIVATIVES OF 1,4-DIHYDROPYRIDINE, ITS PREPARATION PROCEDURE AND THERAPEUTIC COMPOSITION THAT CONTAINS THEM.
CO4750819A1 (en) PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1
ES2060592T3 (en) A THIOESTER AND ITS USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ISCHEMIA AND REPERFUSION SYNDROMES.
DK0429370T3 (en) Hiditl Thiophene Derivatives, Methods of Preparation thereof and Pharmaceutical Agents Containing Them
MX9203577A (en) NEW DERIVATIVES OF SYNERGISTINES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
CO4970804A1 (en) NEW DERIVATIVES OF VITAMIN D3
ES2171306T3 (en) COMPOSED UNDER THE FORM OF A PURE GEOMETRIC ISOMER OR A MIXTURE OF THESE ISOMERS.